Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics.
about
Organometallic Iridium(III) anticancer complexes with new mechanisms of action: NCI-60 screening, mitochondrial targeting, and apoptosis.Potential anticancer heterometallic Fe-Au and Fe-Pd agents: initial mechanistic insights.Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes.Synthesis, Molecular Structure and Cytotoxicity of Molecular Materials Based on Water Soluble Half-Sandwich Rh(III) and Ir(III) Tetranuclear Metalla-Cycles.Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?Regulating the anticancer properties of organometallic dendrimers using pyridylferrocene entities: synthesis, cytotoxicity and DNA binding studies.In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents.Synthesis and characterization of a new class of anti-angiogenic agents based on ruthenium clusters.The influence of RAPTA moieties on the antiproliferative activity of peripheral-functionalised poly(salicylaldiminato) metallodendrimers.Contrasting cellular uptake pathways for chlorido and iodido iminopyridine ruthenium arene anticancer complexes.Distinct cellular fates for KP1019 and NAMI-A determined by X-ray fluorescence imaging of single cells.Electronic State of Sodium trans-[Tetrachloridobis(1H-indazole)ruthenate(III)] (NKP-1339) in Tumor, Liver and Kidney Tissue of a SW480-bearing Mouse.Solvent and Copper Ion-Induced Synthesis of Pyridyl-Pyrazole-3-One Derivatives: Crystal Structure, Cytotoxicity.Osmium-Nitrosyl Oxalato-Bridged Lanthanide-Centered Pentanuclear Complexes - Synthesis, Crystal Structures and Magnetic Properties
P2860
Q36952837-C7392AA2-60F7-4156-8A42-F1D32E8C59EFQ37432620-B51AB133-984E-4C2A-B0C8-B34294201C0BQ38203819-113D839F-20FF-4F27-B99B-69CFBB514762Q38634005-8C5CC366-15D0-40D3-9C91-749B5966A55BQ38710506-DA09E75A-787D-40BC-8A8D-99E2C43F2C62Q38770155-9C51B2E6-80BF-40D9-82D5-1F13EAD1C7CEQ38827745-B36E7A8C-D9AF-41C2-969A-A9D28F579791Q39178846-19E24B2D-A6A6-4AF8-A479-3D97CABD3243Q39246566-235D7FB5-B341-4DA5-99AB-E3DCF0540889Q39247606-D3DE74E0-A76C-416B-94DB-26D9989E0B04Q39294174-706BEEF5-84CA-4898-A1DD-E05C6836E82FQ41883625-90244EF5-8D7E-40E9-8B8B-FD98EB6D3204Q47411821-0024CD22-C87C-448A-A4FC-7A5E0C7A1E0AQ58117720-A1578F3A-98A2-4675-A100-E900A671A514
P2860
Polynuclear ruthenium, osmium and gold complexes. The quest for innovative anticancer chemotherapeutics.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Polynuclear ruthenium, osmium ...... anticancer chemotherapeutics.
@en
Polynuclear ruthenium, osmium ...... anticancer chemotherapeutics.
@nl
type
label
Polynuclear ruthenium, osmium ...... anticancer chemotherapeutics.
@en
Polynuclear ruthenium, osmium ...... anticancer chemotherapeutics.
@nl
prefLabel
Polynuclear ruthenium, osmium ...... anticancer chemotherapeutics.
@en
Polynuclear ruthenium, osmium ...... anticancer chemotherapeutics.
@nl
P50
P1476
Polynuclear ruthenium, osmium ...... anticancer chemotherapeutics.
@en
P304
P356
10.2174/156802611798040769
P577
2011-01-01T00:00:00Z